Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1024.09 - $1201.76 $27.8 Million - $32.6 Million
-27,100 Reduced 41.31%
38,500 $40.5 Million
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $34.7 Million - $42.1 Million
39,300 Added 149.43%
65,600 $68.9 Million
Q1 2024

May 15, 2024

SELL
$902.69 - $993.35 $2.44 Million - $2.68 Million
-2,700 Reduced 9.31%
26,300 $25.3 Million
Q4 2023

Feb 14, 2024

SELL
$775.18 - $881.7 $1.94 Million - $2.2 Million
-2,500 Reduced 7.94%
29,000 $25.5 Million
Q2 2023

Aug 14, 2023

SELL
$700.03 - $830.35 $18.2 Million - $21.6 Million
-26,000 Reduced 45.22%
31,500 $22.6 Million
Q1 2023

May 12, 2023

BUY
$680.49 - $826.97 $16 Million - $19.4 Million
23,500 Added 69.12%
57,500 $47.2 Million
Q4 2022

Feb 10, 2023

SELL
$705.89 - $766.39 $9.88 Million - $10.7 Million
-14,000 Reduced 29.17%
34,000 $24.5 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $15.8 Million - $19.9 Million
27,500 Added 134.15%
48,000 $33.1 Million
Q1 2022

May 16, 2022

SELL
$595.12 - $698.43 $20.5 Million - $24.1 Million
-34,500 Reduced 62.73%
20,500 $14.3 Million
Q4 2021

Feb 08, 2022

BUY
$543.48 - $670.97 $27.2 Million - $33.5 Million
50,000 Added 1000.0%
55,000 $34.7 Million
Q3 2021

Nov 15, 2021

SELL
$574.03 - $680.96 $23.2 Million - $27.5 Million
-40,400 Reduced 88.99%
5,000 $3.03 Million
Q2 2021

Sep 13, 2021

BUY
$472.8 - $558.54 $21.5 Million - $25.4 Million
45,400 New
45,400 $25.4 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.